DS
XRTX

DRW Securities’s XORTX Therapeutics XRTX Stock Holding History

DRW Securities’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,720
Closed -$109K – 1783
2025
Q4 		$109K Buy
+38,720
New +$128K ﹤0.01% 1059

Other funds holding XRTX

KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

DRW Securities's XRTX Position: Q1 2026 in Review

DRW Securities sold out of XORTX Therapeutics (XRTX) in Q1 2026, closing a stake of 38,720 shares — an estimated $109K sold.

DRW Securities first reported a position in XRTX in Q4 2025 and held it in 1 quarter. The position peaked at $109K in Q4 2025. 3 funds tracked by Wall St. Rank hold XRTX as of Q1 2026.

  • DRW Securities reported no remaining XORTX Therapeutics position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 38,720 XORTX Therapeutics shares in Q1 2026, an estimated $109K.
  • DRW Securities first reported a position in XORTX Therapeutics in Q4 2025 and held it in 1 quarter.
  • DRW Securities's XORTX Therapeutics position peaked at $109K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.